|
Diabetes, Vol 44, Issue 2 234-242, Copyright © 1995 by American Diabetes Association
Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats
RG Tilton, K Chang, JR Nyengaard, M Van den Enden, Y Ido and JR Williamson
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri.
These experiments were undertaken to assess the role of sorbitol
dehydrogenase in mediating sorbitol pathway-linked neural and vascular
dysfunction in rats with streptozocin-induced diabetes.
2-methyl-4-[N,N-dimethylsulfamoyl-piperazino]-pyrimidine (S-0773), a
putative inhibitor of sorbitol dehydrogenase, was given in the drinking
water to control and diabetic rats. After 5 weeks of diabetes, glycosylated
hemoglobin levels were increased twofold and were unaffected by S-0773.
Sorbitol levels in diabetic rats were increased 11- to 14-fold in ocular
tissues and sciatic nerve; S-0773 increased sorbitol levels another 4-fold
or more in these same tissues but had much smaller effects in other
tissues. Diabetes-associated increases in fructose levels and
lactate:pyruvate ratios in retina and in sciatic nerve were markedly
attenuated by S-0773. S-0773 also attenuated, but did not completely
normalize, impaired caudal nerve conduction and vascular dysfunction in
ocular tissues, sciatic nerve, and aorta in diabetic rats. These
observations, together with other evidence, suggest that sorbitol
pathway-linked vascular dysfunction (in ocular tissues, peripheral nerve,
and aorta) and electrophysiological dysfunction (in peripheral nerve)
induced by diabetes are more closely linked to increased oxidation of
sorbitol to fructose than to putative osmotic effects of elevated sorbitol
levels or redox and metabolic imbalances associated with reduction of
glucose to sorbitol by aldose reductase.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Y. Lin, A. Ito, T. Asagami, P. S. Tsao, S. Adimoolam, M. Kimoto, H. Tsuji, G. M. Reaven, and J. P. Cooke
Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase
Circulation,
August 20, 2002;
106(8):
987 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE
Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
FASEB J,
August 1, 2000;
14(11):
1548 - 1558.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. KAPOR-DREZGIC, X. ZHOU, T. BABAZONO, J. A. DLUGOSZ, T. HOHMAN, and C. WHITESIDE
Effect of High Glucose on Mesangial Cell Protein Kinase C-{delta} and - is Polyol Pathway-Dependent
J. Am. Soc. Nephrol.,
June 1, 1999;
10(6):
1193 - 1203.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Y. W. lee and S. S. M. Chung
Contributions of polyol pathway to oxidative stress in diabetic cataract
FASEB J,
January 1, 1999;
13(1):
23 - 30.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Luque, L. Hjelmqvist, G. Marfany, O. Danielsson, M. El-Ahmad, B. Persson, H. Jornvall, and R. Gonzalez-Duarte
Sorbitol Dehydrogenase of Drosophila. GENE, PROTEIN, AND EXPRESSION DATA SHOW A TWO-GENE SYSTEM
J. Biol. Chem.,
December 18, 1998;
273(51):
34293 - 34301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uemura, H. Matsushita, W. Li, A. J. Glassford, T. Asagami, K.-H. Lee, D. G. Harrison, and P. S. Tsao
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity : Role of Oxidative Stress
Circ. Res.,
June 22, 2001;
88(12):
1291 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|